Infectious Disease
Likely described in fragmentary form within broader accounts of childhood throat fevers in the late 19th century; the first clearly delineated clinical description is attributed to Zahorsky in 1920.
Herpangina was a febrile illness of childhood that puzzled clinicians for much of the nineteenth and early twentieth centuries, often grouped with other vesicular throat conditions before its distinct identity was established. The condition's viral origin remained obscure until mid-twentieth-century laboratory advances allowed researchers to isolate and characterize the responsible pathogens. Its history reflects the broader arc of virology's emergence as a discipline capable of distinguishing clinically similar infectious illnesses.
Historical Narrative
For most of recorded medical history, herpangina had no independent identity. Ancient and medieval physicians who encountered children suffering from throat ulcers and sudden fevers folded such presentations into broader categories of throat inflammation, often attributing them to imbalances among the four humors as theorized by Galen and his intellectual descendants. Arabic physicians of the medieval Islamic golden age, including Avicenna, catalogued numerous throat ailments in considerable detail, but the specific constellation of features that would later define herpangina remained submerged within larger taxonomies of febrile throat disease.
The condition's emergence as a distinct clinical entity came only in the early twentieth century. The American pediatrician John Zahorsky published a foundational description in 1920, drawing on observations from his St. Louis practice to argue that a particular pattern of small ulcerative lesions appearing at the back of the throat, accompanied by sudden fever in young children, constituted a recognizable and repeatable clinical syndrome. Zahorsky coined the term 'herpangina,' combining the Greek root for creeping lesion with the Latin word for throat, to capture what he perceived as a herpes-like appearance of the sores. He was careful to distinguish this syndrome from herpetic gingivostomatitis and from other febrile throat conditions that had long been lumped together in clinical practice.
Zahorsky's contemporaries were not immediately persuaded. The early twentieth century lacked laboratory tools sufficient to confirm or deny a specific infectious cause, and skeptics questioned whether herpangina represented anything more than a variant presentation of known conditions. The syndrome occupied an ambiguous space in pediatric medicine for several decades, recognized by some clinicians and dismissed by others.
The decisive turning point came in the late 1940s and early 1950s, when virologists Gilbert Dalldorf and Grace Sickles, working at the New York State Department of Health, made a discovery with far-reaching consequences. While investigating poliomyelitis, they inoculated newborn mice with stool specimens from children with a paralytic illness and observed a previously unknown pathogen producing distinctive muscle damage. The viruses they recovered were named Coxsackieviruses after the town of Coxsackie, New York, where the index specimens had been collected. Subsequent investigations through the 1950s revealed that certain Coxsackievirus types were responsible for producing the clinical picture Zahorsky had described three decades earlier, finally anchoring herpangina to a definable biological cause.
This virological identification transformed herpangina from an observational curiosity into a legitimate diagnostic category supported by laboratory science. Epidemiologists through the 1950s and 1960s traced outbreak patterns and confirmed the condition's tendency to circulate in warm months, giving rise to its characterization as a summer illness of childhood. Researchers mapped the various Coxsackievirus serotypes capable of producing the syndrome and began differentiating herpangina from the related hand, foot, and mouth disease, which shared some causative agents but presented with a distinct distribution of lesions. By the latter half of the twentieth century, herpangina had moved from a contested clinical impression into a well-characterized entity within the expanding field of pediatric infectious disease, its history illustrating how careful bedside observation and laboratory science together reshaped the boundaries of disease classification.
Key Historical Figures
Historical narrative only — this page describes how Herpangina was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.